Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 565967, 12 pages
http://dx.doi.org/10.1155/2013/565967
Research Article

Severely Obese Adolescents and Adults Exhibit a Different Association of Circulating Levels of Adipokines and Leukocyte Expression of the Related Receptors with Insulin Resistance

1Department of Clinical Sciences and Community Health, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy
2Istituto Auxologico Italiano, IRCCS, Experimental Laboratory for Auxo-Endocrinological Research, Via Ariosto 13, 20145 Milan, Italy
3Istituto Auxologico Italiano, IRCCS, Division of Metabolic Diseases, Corso Mameli, 199, 28921 Verbania, Italy

Received 2 August 2013; Revised 12 November 2013; Accepted 19 November 2013

Academic Editor: Kristin Eckardt

Copyright © 2013 Antonello E. Rigamonti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Dali-Youcef, M. Mecili, R. Ricci et al., “Metabolic inflammation: connecting obesity and insulin resi stance,” Annales of Medicine, vol. 45, no. 3, pp. 242–253, 2013. View at Google Scholar
  2. F. X. Pi-Sunyer, “The medical risks of obesity,” Obesity Surgery, vol. 12, supplement 1, pp. 5S–11S, 2002. View at Google Scholar · View at Scopus
  3. K. E. Wellen and G. S. Hotamisligil, “Obesity-induced inflammatory changes in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1785–1788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Hotamisligil, “Inflammatory pathways and insulin action,” International Journal of Obesity, vol. 27, supplement 3, pp. S53–S55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tzanavari, P. Giannogonas, and K. P. Karalis, “TNF-α and obesity,” Current Directions in Autoimmunity, vol. 11, pp. 145–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Cabal-Hierro and P. S. Lazo, “Signal transduction by tumor necrosis factor receptors,” Cellular Signalling, vol. 24, no. 6, pp. 1297–1305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Ohashi, N. Ouchi, and Y. Matsuzawa, “Anti-inflammatory and anti-atherogenic properties of adiponectin,” Biochimie, vol. 94, no. 10, pp. 2137–2142, 2012. View at Google Scholar
  8. T. Yamauchi and T. Kadowaki, “Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases,” International Journal of Obesity, vol. 32, supplement 7, pp. S13–S18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Chinetti, C. Zawadski, J. C. Fruchart, and B. Staels, “Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR,” Biochemical and Biophysical Research Communications, vol. 314, no. 1, pp. 151–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. T. L. Pang and P. Narendran, “The distribution of adiponectin receptors on human peripheral blood mononuclear cells,” Annals of the New York Academy of Sciences, vol. 1150, pp. 143–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Weigert, M. Neumeier, J. Wanninger et al., “Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes,” FEBS Letters, vol. 582, no. 12, pp. 1777–1782, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Wolf, D. Wolf, H. Rumpold, B. Enrich, and H. Tilg, “Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes,” Biochemical and Biophysical Research Communications, vol. 323, no. 2, pp. 630–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Tsatsanis, V. Zacharioudaki, A. Androulidaki et al., “Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli,” Biochemical and Biophysical Research Communications, vol. 335, no. 4, pp. 1254–1263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Wulster-Radcliffe, K. M. Ajuwon, J. Wang, J. A. Christian, and M. E. Spurlock, “Adiponectin differentially regulates cytokines in porcine macrophages,” Biochemical and Biophysical Research Communications, vol. 316, no. 3, pp. 924–929, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Ouchi, S. Kihara, Y. Arita et al., “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages,” Circulation, vol. 103, no. 8, pp. 1057–1063, 2001. View at Google Scholar · View at Scopus
  16. Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Hotta, T. Funahashi, Y. Arita et al., “Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1595–1599, 2000. View at Google Scholar · View at Scopus
  18. M. Kumada, S. Kihara, S. Sumitsuji et al., “Association of hypoadiponectinemia with coronary artery disease in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 85–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Weyer, T. Funahashi, S. Tanaka et al., “Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 1930–1935, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Rosenbaum and R. L. Leibel, “The role of leptin in human physiology,” The New England Journal of Medicine, vol. 341, no. 12, pp. 913–915, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Galic, J. S. Oakhill, and G. R. Steinberg, “Adipose tissue as an endocrine organ,” Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 129–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Chiang, M. T. Pritchard, and L. E. Nagy, “Obesity, diabetes mellitus, and liver fibrosis,” The American Journal of Physiology, vol. 300, no. 5, pp. G697–G702, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Sánchez-Margalet, C. Martín-Romero, J. Santos-Alvarez, R. Goberna, S. Najib, and C. Gonzalez-Yanes, “Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 11–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Gorska, K. Popko, A. Stelmaszczyk-Emmel, O. Ciepiela, A. Kucharska, and M. Wasik, “Leptin receptors,” European Journal of Medical Research, vol. 15, supplement 2, pp. 50–54, 2010. View at Google Scholar · View at Scopus
  25. P. C. Tsiotra, V. Pappa, S. A. Raptis, and C. Tsigos, “Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin's actions,” Metabolism, vol. 49, no. 12, pp. 1537–1541, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. E. E. Muller, A. E. Rigamonti, V. D. G. Colonna, V. Locatelli, F. Berti, and S. G. Cella, “GH-related and extra-endocrine actions of GH secretagogues in aging,” Neurobiology of Aging, vol. 23, no. 5, pp. 907–919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Rigamonti, A. I. Pincelli, B. Corrá et al., “Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients,” Journal of Endocrinology, vol. 175, no. 1, pp. R1–R5, 2002. View at Google Scholar · View at Scopus
  28. M. Tesauro, F. Schinzari, M. Iantorno et al., “Ghrelin improves endothelial function in patients with metabolic syndrome,” Circulation, vol. 112, no. 19, pp. 2986–2992, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings, “Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive contrls,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1630–1635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. D. Howard, S. D. Feighner, D. F. Cully et al., “A receptor in pituitary and hypothalamus that functions in growth hormone release,” Science, vol. 273, no. 5277, pp. 974–977, 1996. View at Google Scholar · View at Scopus
  31. A. Laviano, A. Molfino, S. Rianda et al., “The growth hormone secretagogue receptor (Ghs-R),” Current Pharmaceutical Design, vol. 18, no. 31, pp. 4749–4754, 2012. View at Google Scholar
  32. A. J. van der Lely, M. Tschöp, M. L. Heiman, and E. Ghigo, “Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin,” Endocrine Reviews, vol. 25, no. 3, pp. 426–457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Hattori, T. Saito, T. Yagyu, B.-H. Jiang, K. Kitagawa, and C. Inagaki, “GH, GH receptor, GH secretagogue receptor, and Ghrelin expression in human T cells, B cells, and neutrophils,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4284–4291, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Granado, T. Priego, A. I. Martín, M. Á. Villanúa, and A. López-Calderón, “Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats,” The American Journal of Physiology, vol. 288, no. 3, pp. E486–E492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. N. Soriano, L. G. Nicoli, E. C. Carnio, and L. G. S. Branco, “Exogenous ghrelin attenuates endotoxin fever in rats,” Peptides, vol. 32, no. 11, pp. 2372–2376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. R. B. Goldberg, “Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3171–3182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Miyamoto, J. J. Carrero, and P. Stenvinkel, “Inflammation as a risk factor and target for therapy in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 6, pp. 662–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. I. Cohen, L. Maayan, and A. Convit, “Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines,” Diabetology and Metabolic Syndrome, vol. 4, no. 1, article 26, 2012. View at Google Scholar
  40. O. Åstrand, M. Carlsson, I. Nilsson, T. Lindström, M. Borga, and F. H. Nystrom, “Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects,” European Journal of Endocrinology, vol. 163, no. 6, pp. 879–885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Wärnberg, L. A. Moreno, M. I. Mesana, and A. Marcos, “Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study,” International Journal of Obesity, vol. 28, supplement 3, pp. S59–S63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Robert Koch Institut, “Bundes-Gesundheits Survey 1998-Questionnaire,” in Gesundheitswesen, Issue 61, Robert Koch Institut, Ed., Georg Thieme, Stuttgart, Germany, 1999. View at Google Scholar
  43. H. J. Harwood Jr., “The adipocyte as an endocrine organ in the regulation of metabolic homeostasis,” Neuropharmacology, vol. 63, no. 1, pp. 57–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Lolmède, C. Duffaut, A. Zakaroff-Girard, and A. Bouloumié, “Immune cells in adipose tissue: key players in metabolic disorders,” Diabetes and Metabolism, vol. 37, no. 4, pp. 283–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Baatar, K. Patel, and D. D. Taub, “The effects of ghrelin on inflammation and the immune system,” Molecular and Cellular Endocrinology, vol. 340, no. 1, pp. 44–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. I. Odegaard and A. Chawla, “Mechanisms of macrophage activation in obesity-induced insulin resistance,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 11, pp. 619–626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. M. van Greevenbroek, C. G. Schalkwijk, and C. D. Stehouwer, “Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences,” Netherlands Journal of Medicine, vol. 71, no. 4, pp. 174–187, 2013. View at Google Scholar
  48. J. Ye, “Mechanisms of insulin resistance in obesity,” Frontiers of Medicine, vol. 7, no. 1, pp. 14–24, 2013. View at Google Scholar
  49. R. Weiss, S. E. Taksali, S. Dufour et al., “The “Obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3731–3737, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Cook, M. Weitzman, P. Auinger, M. Nguyen, and W. H. Dietz, “Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Pediatrics and Adolescent Medicine, vol. 157, no. 8, pp. 821–827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Choi, L. Joseph, and L. Pilote, “Obesity and C-reactive protein in various populations: a systematic review and meta-analysis,” Obesity Reviews, vol. 14, no. 3, pp. 232–244, 2013. View at Google Scholar
  52. M. Fogeda, L. Gallart, C. Gutiérrez et al., “High expression of tumor necrosis factor a receptors in peripheral blood mononuclear cells of obese type 2 diabetic women,” European Cytokine Network, vol. 15, no. 1, pp. 60–66, 2004. View at Google Scholar · View at Scopus
  53. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, “Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409–2415, 1995. View at Google Scholar · View at Scopus
  54. H. Hauner, M. Bender, B. Haastert, and F. Hube, “Plasma concentrations of soluble TNF-alpha receptors in obese subjects,” International Journal of Obesity, vol. 22, no. 12, pp. 1239–1243, 1998. View at Google Scholar · View at Scopus
  55. B. Zahorska-Markiewicz, J. Janowska, M. Olszanecka-Glinianowicz, and A. Zurakowski, “Serum concentrations of TNF-α and soluble TNF-α receptors in obesity,” International Journal of Obesity, vol. 24, no. 11, pp. 1392–1395, 2000. View at Google Scholar · View at Scopus
  56. S. J. Dunmore and J. E. Brown, “The role of adipokines in beta-cell failure of type 2 diabetes,” Journal of Endocrinology, vol. 216, no. 1, pp. T37–T45, 2013. View at Google Scholar
  57. D. G. Baskin, R. J. Seeley, J. L. Kuijper et al., “Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting,” Diabetes, vol. 47, no. 4, pp. 538–543, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. J. G. Mercer, K. M. Moar, D. V. Rayner, P. Trayhurn, and N. Hoggard, “Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice,” FEBS Letters, vol. 402, no. 2-3, pp. 185–188, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Zimmet, A. Hodge, M. Nicolson et al., “Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study,” British Medical Journal, vol. 313, no. 7063, pp. 965–969, 1996. View at Google Scholar · View at Scopus
  60. H. Komarowska, M. Jaskula, A. Stangierski et al., “Influence of ghrelin on energy balance and endocrine physiology,” Neuroendocrinology Letters, vol. 33, no. 8, pp. 749–756, 2012. View at Google Scholar
  61. M. Tesauro, F. Schinzari, M. Caramanti, R. Lauro, and C. Cardillo, “Cardiovascular and metabolic effects of ghrelin,” Current Diabetes Reviews, vol. 6, no. 4, pp. 228–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. S. M. Pöykkö, E. Kellokoski, S. Hörkkö et al., “Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes,” vol. 52, no. 10, pp. 2546–2553, 2003. View at Google Scholar
  63. K. Kotani, N. Sakane, K. Saiga et al., “Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome,” Archives of Medical Research, vol. 37, no. 7, pp. 903–906, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Frascarelli, S. Ghelardoni, S. Ronca-Testoni, and R. Zucchi, “Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart,” Basic Research in Cardiology, vol. 98, no. 6, pp. 401–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Baessler, M. Fischer, B. Mayer et al., “Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease,” Human Molecular Genetics, vol. 16, no. 8, pp. 887–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Delgado and D. Ganea, “Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1146–1151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. P. J. Verhulst and I. Depoortere, “Ghrelin's second life: from appetite stimulator to glucose regulator,” World Journal of Gastroenterology, vol. 18, no. 25, pp. 3183–3195, 2012. View at Google Scholar
  68. K. Rabe, M. Lehrke, K. G. Parhofer, and U. C. Broedl, “Adipokines and insulin resistance,” Molecular Medicine, vol. 14, no. 11-12, pp. 741–751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Su, W. B. Lau, and X.-L. Ma, “Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 12, pp. 897–904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Hattori, K. Akimoto, S. S. Gross, S. Hattori, and K. Kasai, “Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats,” Diabetologia, vol. 48, no. 6, pp. 1066–1074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Kos and J. P. H. Wilding, “Adipokines: emerging therapeutic targets,” Current Opinion in Investigational Drugs, vol. 10, no. 10, pp. 1061–1068, 2009. View at Google Scholar · View at Scopus
  73. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 71, 2013. View at Google Scholar
  74. I. Falcão-Pires, P. Castro-Chaves, D. Miranda-Silva et al., “Physiological, pathological and potential therapeutic roles of adipokines,” Drug Discovery Today, vol. 17, no. 15-16, pp. 880–889, 2012. View at Google Scholar